130 related articles for article (PubMed ID: 36657444)
1. Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8
Riegel D; Romero-Fernández E; Simon M; Adenugba AR; Singer K; Mayr R; Weber F; Kleemann M; Imbusch CD; Kreutz M; Brors B; Ugele I; Werner JM; Siska PJ; Schmidl C
Mol Cell; 2023 Feb; 83(4):622-636.e10. PubMed ID: 36657444
[TBL] [Abstract][Full Text] [Related]
2. Exhaustion-associated regulatory regions in CD8
Mognol GP; Spreafico R; Wong V; Scott-Browne JP; Togher S; Hoffmann A; Hogan PG; Rao A; Trifari S
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2776-E2785. PubMed ID: 28283662
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq.
Carmona SJ; Siddiqui I; Bilous M; Held W; Gfeller D
Oncoimmunology; 2020; 9(1):1737369. PubMed ID: 32313720
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
5. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Balança CC; Salvioni A; Scarlata CM; Michelas M; Martinez-Gomez C; Gomez-Roca C; Sarradin V; Tosolini M; Valle C; Pont F; Ferron G; Gladieff L; Vergez S; Dupret-Bories A; Mery E; Rochaix P; Fournié JJ; Delord JP; Devaud C; Martinez A; Ayyoub M
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33332284
[TBL] [Abstract][Full Text] [Related]
6. CD8
He B; Xing S; Chen C; Gao P; Teng L; Shan Q; Gullicksrud JA; Martin MD; Yu S; Harty JT; Badovinac VP; Tan K; Xue HH
Immunity; 2016 Dec; 45(6):1341-1354. PubMed ID: 27986453
[TBL] [Abstract][Full Text] [Related]
7. Single-cell chromatin accessibility identifies enhancer networks driving gene expression during spinal cord development in mouse.
Shu M; Hong D; Lin H; Zhang J; Luo Z; Du Y; Sun Z; Yin M; Yin Y; Liu L; Bao S; Liu Z; Lu F; Huang J; Dai J
Dev Cell; 2022 Dec; 57(24):2761-2775.e6. PubMed ID: 36495874
[TBL] [Abstract][Full Text] [Related]
8. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.
Singer M; Wang C; Cong L; Marjanovic ND; Kowalczyk MS; Zhang H; Nyman J; Sakuishi K; Kurtulus S; Gennert D; Xia J; Kwon JYH; Nevin J; Herbst RH; Yanai I; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
Cell; 2016 Sep; 166(6):1500-1511.e9. PubMed ID: 27610572
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence.
Belk JA; Yao W; Ly N; Freitas KA; Chen YT; Shi Q; Valencia AM; Shifrut E; Kale N; Yost KE; Duffy CV; Daniel B; Hwee MA; Miao Z; Ashworth A; Mackall CL; Marson A; Carnevale J; Vardhana SA; Satpathy AT
Cancer Cell; 2022 Jul; 40(7):768-786.e7. PubMed ID: 35750052
[TBL] [Abstract][Full Text] [Related]
10. Discovery of stimulation-responsive immune enhancers with CRISPR activation.
Simeonov DR; Gowen BG; Boontanrart M; Roth TL; Gagnon JD; Mumbach MR; Satpathy AT; Lee Y; Bray NL; Chan AY; Lituiev DS; Nguyen ML; Gate RE; Subramaniam M; Li Z; Woo JM; Mitros T; Ray GJ; Curie GL; Naddaf N; Chu JS; Ma H; Boyer E; Van Gool F; Huang H; Liu R; Tobin VR; Schumann K; Daly MJ; Farh KK; Ansel KM; Ye CJ; Greenleaf WJ; Anderson MS; Bluestone JA; Chang HY; Corn JE; Marson A
Nature; 2017 Sep; 549(7670):111-115. PubMed ID: 28854172
[TBL] [Abstract][Full Text] [Related]
11. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
[TBL] [Abstract][Full Text] [Related]
12. TRlnc: a comprehensive database for human transcriptional regulatory information of lncRNAs.
Li Y; Li X; Yang Y; Li M; Qian F; Tang Z; Zhao J; Zhang J; Bai X; Jiang Y; Zhou J; Zhang Y; Zhou L; Xie J; Li E; Wang Q; Li C
Brief Bioinform; 2021 Mar; 22(2):1929-1939. PubMed ID: 32047897
[TBL] [Abstract][Full Text] [Related]
13. The chromatin accessibility landscape of primary human cancers.
Corces MR; Granja JM; Shams S; Louie BH; Seoane JA; Zhou W; Silva TC; Groeneveld C; Wong CK; Cho SW; Satpathy AT; Mumbach MR; Hoadley KA; Robertson AG; Sheffield NC; Felau I; Castro MAA; Berman BP; Staudt LM; Zenklusen JC; Laird PW; Curtis C; ; Greenleaf WJ; Chang HY
Science; 2018 Oct; 362(6413):. PubMed ID: 30361341
[TBL] [Abstract][Full Text] [Related]
14. Chromatin states define tumour-specific T cell dysfunction and reprogramming.
Philip M; Fairchild L; Sun L; Horste EL; Camara S; Shakiba M; Scott AC; Viale A; Lauer P; Merghoub T; Hellmann MD; Wolchok JD; Leslie CS; Schietinger A
Nature; 2017 May; 545(7655):452-456. PubMed ID: 28514453
[TBL] [Abstract][Full Text] [Related]
15. A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma.
Kourtis N; Wang Q; Wang B; Oswald E; Adler C; Cherravuru S; Malahias E; Zhang L; Golubov J; Wei Q; Lemus S; Ni M; Ding Y; Wei Y; Atwal GS; Thurston G; Macdonald LE; Murphy AJ; Dhanik A; Sleeman MA; Tykodi SS; Skokos D
Nat Cancer; 2022 Jul; 3(7):885-898. PubMed ID: 35668194
[TBL] [Abstract][Full Text] [Related]
16. NR4A transcription factors limit CAR T cell function in solid tumours.
Chen J; López-Moyado IF; Seo H; Lio CJ; Hempleman LJ; Sekiya T; Yoshimura A; Scott-Browne JP; Rao A
Nature; 2019 Mar; 567(7749):530-534. PubMed ID: 30814732
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial immunotherapy induces tumor-infiltrating CD8
Van Braeckel-Budimir N; Dolina JS; Wei J; Wang X; Chen SH; Santiago P; Tu G; Micci L; Al-Khami AA; Pfister S; Ram S; Sundar P; Thomas G; Long H; Yang W; Potluri S; Salek-Ardakani S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903555
[TBL] [Abstract][Full Text] [Related]
18. LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion.
Marasca F; Sinha S; Vadalà R; Polimeni B; Ranzani V; Paraboschi EM; Burattin FV; Ghilotti M; Crosti M; Negri ML; Campagnoli S; Notarbartolo S; Sartore-Bianchi A; Siena S; Prati D; Montini G; Viale G; Torre O; Harari S; Grifantini R; Soldà G; Biffo S; Abrignani S; Bodega B
Nat Genet; 2022 Feb; 54(2):180-193. PubMed ID: 35039641
[TBL] [Abstract][Full Text] [Related]
19. Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes.
Lee M; Li J; Li J; Fang S; Zhang J; Vo ATT; Han W; Zeng H; Isgandarova S; Martinez-Moczygemba M; Zhou Y; Sun D; Huang Y
Cancer Res; 2021 Apr; 81(8):1965-1976. PubMed ID: 33589517
[TBL] [Abstract][Full Text] [Related]
20. Protocol for the isolation of CD8+ tumor-infiltrating lymphocytes from human tumors and their characterization by single-cell immune profiling and multiome.
Anadon CM; Zhang C; Wang X; Cen L; Conejo-Garcia JR; Yu X
STAR Protoc; 2022 Sep; 3(3):101649. PubMed ID: 36065294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
